These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 564406)

  • 1. Preparation and biological actions of some symmetrically N,N-disubstituted dopamines.
    Cannon JG; Hsu FL; Long JP; Flynn JR; Costall B; Naylor RJ
    J Med Chem; 1978 Mar; 21(3):248-53. PubMed ID: 564406
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multiple receptors for brain dopamine in behavior regulation: concept of dopamine-E and dopamine-I receptors.
    Cools AR; van Rossum JM
    Life Sci; 1980 Oct; 27(14):1237-53. PubMed ID: 6255271
    [No Abstract]   [Full Text] [Related]  

  • 3. Inhibition of apomorphine-induced behaviors by derivatives of 2-amino-1, 2, 3, 4-tetrahydronaphthalene.
    Rusterholz DB; Long JP; Flynn JR; Glyn JR; Barfknecht CF; Lind RW; Johnson AK
    Arch Int Pharmacodyn Ther; 1978 Apr; 232(2):246-60. PubMed ID: 567044
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aporphines, 21. (1,2) Dopaminergic activity of aporphine and benzylisoquinoline derivatives. Synthesis of 8-hydroxyaporphines and 1-(hydroxybenzyl)-2-n-propyl-1,2,3,4-tetrahydroisoquinolines.
    Costall B; Naylor RJ
    J Med Chem; 1977 Feb; 20(2):190-6. PubMed ID: 556776
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rotational behaviour elicited by intracerebral injections of apomorphine and pergolide in 6-hydroxy-dopamine-lesioned rats. II: The striatum of the rat is heterogeneously organized for rotational behaviour.
    Herrera-Marschitz M; Forster C; Ungerstedt U
    Acta Physiol Scand; 1985 Nov; 125(3):529-35. PubMed ID: 3936339
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Centrally acting emetics. 10. Rigid dopamine congeners derived from octahydrobenzo[f]quinoline.
    Cannon JG; Hatheway GJ
    J Med Chem; 1976 Aug; 19(8):987-93. PubMed ID: 184283
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 6-hydroxydopamine treatments enhance behavioral responses to intracerebral microinjection of D1- and D2-dopamine agonists into nucleus accumbens and striatum without changing dopamine antagonist binding.
    Breese GR; Duncan GE; Napier TC; Bondy SC; Iorio LC; Mueller RA
    J Pharmacol Exp Ther; 1987 Jan; 240(1):167-76. PubMed ID: 3100767
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Conformationally restricted congeners of dopamine derived from 2-aminoindan.
    Cannon JG; Perez JA; Bhatnagar RK; Long JP; Sharabi FM
    J Med Chem; 1982 Dec; 25(12):1442-6. PubMed ID: 7154005
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rigid congeners of dopamine based on octahydrobenzo[f]quinoline: peripheral and central effects.
    Cannon JG; Suarez-Gutierrez C; Lee T; Long JP; Costall B; Fortune DH; Naylor RJ
    J Med Chem; 1979 Apr; 22(4):341-7. PubMed ID: 571020
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Substituted benzamides as cerebral dopamine antagonists in rodents.
    Elliott PN; Jenner P; Huizing G; Marsden CD; Miller R
    Neuropharmacology; 1977 May; 16(5):333-42. PubMed ID: 559256
    [No Abstract]   [Full Text] [Related]  

  • 11. Antipsychotic substances and dopamine in the rat brain; behavioral studies reveal distinct dopamine receptor systems.
    Van Ree JM; Elands J; Király I; Wolterink G
    Eur J Pharmacol; 1989 Aug; 166(3):441-52. PubMed ID: 2572429
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Peter H. Kelly, Paul W. Seviour and Susan D. Iversen (1975) "Amphetamine and apomorphine responses in the rat following 6-OHDA lesions of the nucleus accumbens septi and corpus striatum" [Brain Res. 94 (3) 507-522].
    Iversen SD
    Brain Res; 2016 Aug; 1645():36-7. PubMed ID: 27287245
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The mesolimbic nucleus accumbens is critically involved with the mediation of the motor inhibitory and facilitatory effects of dopamine agonists on mouse spontaneous climbing behaviour.
    Costall B; Eniojukan JF; Naylor RJ
    Eur J Pharmacol; 1983 Dec; 96(3-4):201-10. PubMed ID: 6426976
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Behavioral and neurochemical modifications induced by apomorphine treatment.
    Piervincenzo P; Luciana G; Laura C; Giuseppe A
    Neurosci Lett; 1989 May; 100(1-3):265-70. PubMed ID: 2761776
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Dependence of the antipsychotic effect of neuroleptics on their dopamine-blocking properties].
    Arushanian EB
    Farmakol Toksikol; 1982; 45(5):118-26. PubMed ID: 6128251
    [No Abstract]   [Full Text] [Related]  

  • 16. Gamma-type endorphins and brain dopaminergic systems.
    van Ree JM; Elands J; Kiraly I; Wolterink G
    Prog Clin Biol Res; 1990; 328():287-90. PubMed ID: 1968266
    [No Abstract]   [Full Text] [Related]  

  • 17. Dopamine receptor sensitivity in brain and retina of rats during aging.
    Govoni S; Loddo P; Spano PF; Trabucchi M
    Brain Res; 1977 Dec; 138(3):565-70. PubMed ID: 597726
    [No Abstract]   [Full Text] [Related]  

  • 18. Neurotensin effects on brain dopaminergic systems.
    Haubrich DR; Martin GE; Pflueger AB; Williams M
    Brain Res; 1982 Jan; 231(1):216-21. PubMed ID: 7198926
    [No Abstract]   [Full Text] [Related]  

  • 19. On the ability of N-chloroethyl aporphine derivatives to cause irreversible inhibition of dopamine receptor mechanisms.
    Costall B; Fortune DH; Granchelli FE; Law SJ; Naylor RJ; Neumeyer JL; Nohria V
    J Pharm Pharmacol; 1980 Aug; 32(8):571-6. PubMed ID: 6106696
    [No Abstract]   [Full Text] [Related]  

  • 20. Cis- and trans-4-n-Propyl-1,2,3,4,4a,5,6,10b-octahydrobenzo(f)quinolines.
    Cannon JG; Koble-Suarez C; Long JP; Ilhan M; Bhatnagar RK
    J Pharm Sci; 1985 Jun; 74(6):672-5. PubMed ID: 4040568
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.